All Phenotypes Epas1<tm1Mcs> MGI Mouse

About Help FAQ

Phenotypes associated with this allele

Allele Symbol
Allele Name
Allele ID

Epas1^tm1Mcs
targeted mutation 1, M Celeste Simon
MGI:3526731

Summary

9 genotypes

Jump to	Allelic Composition	Genetic Background	Genotype ID
cn1	Egln1^tm2.1Fsl/Egln1^tm2.1Fsl Epas1^tm1Mcs/Epas1^tm1Mcs Gt(ROSA)26Sor^{tm9(cre/ESR1)Arte}/Gt(ROSA)26Sor⁺	B6.Cg-Gt(ROSA)26Sor^{tm9(cre/ESR1)Arte} Egln1^tm2.1Fsl Epas1^tm1Mcs	MGI:5525147
cn2	Epas1^tm1Mcs/Epas1^tm1Mcs Hif1a^tm3Rsjo/Hif1a^tm3Rsjo Vhl^tm1Jae/Vhl^tm1Jae Tg(Sp7-tTA,tetO-EGFP/cre)1Amc/0	involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * CD-1	MGI:5432005
cn3	Epas1^tm1Mcs/Epas1^tm1Mcs Tg(Sp7-tTA,tetO-EGFP/cre)1Amc/0	involves: 129S1/Sv * 129X1/SvJ * CD-1	MGI:5432004
cn4	Epas1^tm1Mcs/Epas1^tm1Mcs Hif1a^tm3Rsjo/Hif1a^tm3Rsjo Tg(Sp7-tTA,tetO-EGFP/cre)1Amc/0	involves: 129S1/Sv * 129X1/SvJ * CD-1	MGI:5432003
cn5	Epas1^tm1Mcs/Epas1^tm1Mcs Vhl^tm1Jae/Vhl^tm1Jae Tg(Sp7-tTA,tetO-EGFP/cre)1Amc/0	involves: 129S4/SvJae * 129X1/SvJ * CD-1	MGI:5432007
cn6	Egln1^tm1.1Brei/Egln1^tm1.1Brei Epas1^tm1Mcs/Epas1^tm1Mcs Tg(CD68-icre)1Bwlx/0	involves: 129X1/SvJ * C57BL/6	MGI:5568400
cn7	Epas1^tm1Mcs/Epas1^tm1Mcs Tg(CD68-icre)1Bwlx/0	involves: 129X1/SvJ * C57BL/6	MGI:5568403
cn8	Epas1^tm1Mcs/Epas1^tm1.1Mcs Tg(CAG-cre/Esr1*)5Amc/0	involves: 129X1/SvJ * C57BL/6 * CBA	MGI:6724166
cn9	Epas1^tm1Mcs/Epas1^tm1.1Mcs Ndor1^{Tg(UBC-cre/ERT2)1Ejb}/0	involves: 129X1/SvJ * FVB/N	MGI:3710346

Allelic Composition	Egln1^tm2.1Fsl/Egln1^tm2.1Fsl Epas1^tm1Mcs/Epas1^tm1Mcs Gt(ROSA)26Sor^{tm9(cre/ESR1)Arte}/Gt(ROSA)26Sor⁺
Genetic Background	B6.Cg-Gt(ROSA)26Sor^{tm9(cre/ESR1)Arte} Egln1^tm2.1Fsl Epas1^tm1Mcs

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Egln1^tm2.1Fsl mutation (0 available); any Egln1 mutation (22 available)
Epas1^tm1Mcs mutation (1 available); any Epas1 mutation (66 available)
Gt(ROSA)26Sor^{tm9(cre/ESR1)Arte} mutation (2 available); any Gt(ROSA)26Sor mutation (994 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

hematopoietic system

hematopoietic system phenotype ( J:202737 )

N	• hematocrit level, erythropoietin level and spleen architecture and weight are similar to mice without cre/ESR1 allele • the Epas1 allele functions to rescue the erythrocytosis phenotype

mortality/aging

premature death ( J:202737 )

• survival is improved relative to mice carrying the Egln1 null allele, but not to control levels

Allelic Composition	Epas1^tm1Mcs/Epas1^tm1Mcs Hif1a^tm3Rsjo/Hif1a^tm3Rsjo Vhl^tm1Jae/Vhl^tm1Jae Tg(Sp7-tTA,tetO-EGFP/cre)1Amc/0
Genetic Background	involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * CD-1

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Epas1^tm1Mcs mutation (1 available); any Epas1 mutation (66 available)
Hif1a^tm3Rsjo mutation (3 available); any Hif1a mutation (50 available)
Tg(Sp7-tTA,tetO-EGFP/cre)1Amc mutation (2 available)
Vhl^tm1Jae mutation (2 available); any Vhl mutation (17 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

skeleton

decreased trabecular bone volume ( J:186085 )

decreased bone trabecula number ( J:186085 )

hematopoietic system

hematopoietic system phenotype ( J:186085 )

N	• mice exhibit normal frequencies of KLS cells (hematopoietic stem cells and multipotential progenitors) numbers of red blood cells and lymphocytes and hematocrit

homeostasis/metabolism

decreased circulating erythropoietin level ( J:186085 )

Allelic Composition	Epas1^tm1Mcs/Epas1^tm1Mcs Tg(Sp7-tTA,tetO-EGFP/cre)1Amc/0
Genetic Background	involves: 129S1/Sv * 129X1/SvJ * CD-1

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Epas1^tm1Mcs mutation (1 available); any Epas1 mutation (66 available)
Tg(Sp7-tTA,tetO-EGFP/cre)1Amc mutation (2 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

hematopoietic system

decreased erythroid progenitor cell number ( J:186085 )

• decreased frequency of CD71+/Ter119+ cells in the bone marrow

Allelic Composition	Epas1^tm1Mcs/Epas1^tm1Mcs Hif1a^tm3Rsjo/Hif1a^tm3Rsjo Tg(Sp7-tTA,tetO-EGFP/cre)1Amc/0
Genetic Background	involves: 129S1/Sv * 129X1/SvJ * CD-1

Find Mice

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

hematopoietic system

hematopoietic system phenotype ( J:186085 )

N	• mice exhibit normal hematopoietic stem cell frequency

decreased erythroid progenitor cell number ( J:186085 )

• decreased frequency of CD71+/Ter119+ cells in the bone marrow

skeleton

decreased trabecular bone volume ( J:186085 )

Allelic Composition	Epas1^tm1Mcs/Epas1^tm1Mcs Vhl^tm1Jae/Vhl^tm1Jae Tg(Sp7-tTA,tetO-EGFP/cre)1Amc/0
Genetic Background	involves: 129S4/SvJae * 129X1/SvJ * CD-1

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Epas1^tm1Mcs mutation (1 available); any Epas1 mutation (66 available)
Tg(Sp7-tTA,tetO-EGFP/cre)1Amc mutation (2 available)
Vhl^tm1Jae mutation (2 available); any Vhl mutation (17 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

hematopoietic system

hematopoietic system phenotype ( J:186085 )

N	• mice exhibit normal hematocrit

homeostasis/metabolism

decreased circulating erythropoietin level ( J:186085 )

Allelic Composition	Egln1^tm1.1Brei/Egln1^tm1.1Brei Epas1^tm1Mcs/Epas1^tm1Mcs Tg(CD68-icre)1Bwlx/0
Genetic Background	involves: 129X1/SvJ * C57BL/6

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Egln1^tm1.1Brei mutation (0 available); any Egln1 mutation (22 available)
Epas1^tm1Mcs mutation (1 available); any Epas1 mutation (66 available)
Tg(CD68-icre)1Bwlx mutation (0 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

mortality/aging

mortality/aging ( J:194598 )

N	• no premature death is observed

hematopoietic system

hematopoietic system phenotype ( J:194598 )

N	• erythropoiesis phenotype seen in Phd2 single mutants is absent from double mutants

decreased hematocrit ( J:194598 )

• HCT is lower than wild type

decreased hemoglobin content ( J:194598 )

• lower than in wild-type

Allelic Composition	Epas1^tm1Mcs/Epas1^tm1Mcs Tg(CD68-icre)1Bwlx/0
Genetic Background	involves: 129X1/SvJ * C57BL/6

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Epas1^tm1Mcs mutation (1 available); any Epas1 mutation (66 available)
Tg(CD68-icre)1Bwlx mutation (0 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

mortality/aging

mortality/aging ( J:194598 )

N	• no premature death observed

Allelic Composition	Epas1^tm1Mcs/Epas1^tm1.1Mcs Tg(CAG-cre/Esr1*)5Amc/0
Genetic Background	involves: 129X1/SvJ * C57BL/6 * CBA

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Epas1^tm1.1Mcs mutation (0 available); any Epas1 mutation (66 available)
Epas1^tm1Mcs mutation (1 available); any Epas1 mutation (66 available)
Tg(CAG-cre/Esr1*)5Amc mutation (10 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

cardiovascular system

cardiovascular system phenotype ( J:302384 )

N	• tamoxifen-treated mice exhibit normal carotid body morphology

heart left ventricle hypertrophy ( J:302384 )

• likely secondary to anemia in tamoxifen-treated

abnormal type I cell of carotid body physiology ( J:302384 )

• impaired responsiveness to hypoxia with reduced secretory rate in tamoxifen-treated mice

• lower shifted quantal charge and reduced mean charge per event in tamoxifen-treated mice exposed to mild stimuli

• reduced increase in NADH and mitochondrial function induced by hypoxia in tamoxifen-treated mice

• however, tamoxifen-treated mice exhibit normal hypercapnia and depolarization with high extracellular potassium ion, and normal secretion induced by CO2 and high potassium ion

hematopoietic system

anemia ( J:302384 )

• in tamoxifen-treated mice

decreased hematocrit ( J:302384 )

• in tamoxifen-treated mice

homeostasis/metabolism

abnormal physiological response to hypoxia ( J:302384 )

• decreased hypoxic ventilatory response in tamoxifen-treated mice exposed to hypoxic conditions

• however, response to hypercapnia is normal and tamoxifen-treated mice exhibit a small transient hyperventilatory response at the onset of exposure to hypoxia

growth/size/body

heart left ventricle hypertrophy ( J:302384 )

• likely secondary to anemia in tamoxifen-treated

muscle

heart left ventricle hypertrophy ( J:302384 )

• likely secondary to anemia in tamoxifen-treated

nervous system

abnormal type I cell of carotid body physiology ( J:302384 )

• impaired responsiveness to hypoxia with reduced secretory rate in tamoxifen-treated mice

• lower shifted quantal charge and reduced mean charge per event in tamoxifen-treated mice exposed to mild stimuli

• reduced increase in NADH and mitochondrial function induced by hypoxia in tamoxifen-treated mice

• however, tamoxifen-treated mice exhibit normal hypercapnia and depolarization with high extracellular potassium ion, and normal secretion induced by CO2 and high potassium ion

Allelic Composition	Epas1^tm1Mcs/Epas1^tm1.1Mcs Ndor1^{Tg(UBC-cre/ERT2)1Ejb}/0
Genetic Background	involves: 129X1/SvJ * FVB/N

Find Mice

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

hematopoietic system

enlarged spleen ( J:119731 )

• spleens are enlarged relative to controls (0.5% spleen weight to body weight vs. ~0.4% in controls)

anemia ( J:119731 )

• occurs after postnatal cre induction

abnormal proerythroblast morphology ( J:119731 )

• erythroid progenitors from bone marrow form ~50% fewer erythroid burst-forming units (BFU-E) and colony-forming units (CFU-E) in culture than control cells, whereas erythroid progenitors from the spleen form more BFU-E and CFU-E

• there are fewer CD71+ immature erythroid progenitors in the bone marrow, and a higher percentage of CD71+ /Ter119+ double positive cells in the spleen

decreased erythrocyte cell number ( J:119731 )

• with acute deletion of Epas1 at 6-8 weeks induced by tamoxifen administration, animals have decreased red blood cell numbers relative to controls

decreased hematocrit ( J:119731 )

• with acute deletion of Epas1 at 6-8 weeks induced by tamoxifen administration, animals have decreased hematocrit relative to controls

decreased hemoglobin content ( J:119731 )

• with acute deletion of Epas1 at 6-8 weeks induced by tamoxifen administration, animals have decreased hemoglobin levels relative to controls

reticulocytopenia ( J:119731 )

• numbers are decreased compared to controls

abnormal hematopoietic system physiology ( J:119731 )

• mice show weak induction of erythropoietin after phenylhydrazine treatment

immune system

enlarged spleen ( J:119731 )

• spleens are enlarged relative to controls (0.5% spleen weight to body weight vs. ~0.4% in controls)

growth/size/body

enlarged spleen ( J:119731 )

• spleens are enlarged relative to controls (0.5% spleen weight to body weight vs. ~0.4% in controls)

Contributing Projects: Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support.	last database update 12/17/2024 MGI 6.24